Adherence management for patients with cancer taking capecitabine: A prospective two-arm cohort study

BMJ Open

Volumn 3, Issue 7, 2013, Pages

  Krolop, Linda ^a   Ko, Yon Dschun ^b   Schwindt, Peter Florian ^c   Schumacher, Claudia ^d   Fimmers, Rolf ^a   Jaehde, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Johanniter Krankenhaus   (Germany)

^c Oncology Practice   (Germany)

^d St Elisabeth Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER OF UNKNOWN PRIMARY SITE; CLINICAL OBSERVATION; COHORT ANALYSIS; COLORECTAL CANCER; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OBSERVATIONAL STUDY; OVARY CANCER; PANCREAS CANCER; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACEUTICAL CARE; PROSPECTIVE STUDY; STOMACH CANCER; TREATMENT OUTCOME;

EID: 84880587301     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003139     Document Type: Article

References (30)

1. Findlay M, Minckwitz G Von, Wardley A. Effective oral chemotherapy for breast cancer: pillars of strength. Ann Oncol 2008;19:212-22. (Pubitemid 351201700)
2. Weingart SN, Brown E, Bach PB, et al. NCCN Task Force Report: oral chemotherapy. J Natl Compr Canc Netw 2008;6(Suppl 3):S1-14. (Pubitemid 351497279)
3. Halfdanarson TR, Jatoi A. Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Curr Oncol Rep 2010;12:247-52.
4. Schott S, Schneeweiss A, Reinhardt J, et al. Acceptance of oral chemotherapy in breast cancer patients-a survey study. BMC Cancer 2011;11:129.
5. Górnaś M, Szczylik C. Oral treatment of metastatic breast cancer with capecitabine: what influences the decision-making process? Eur J Cancer Care (Engl) 2010;19:131-6.
6. Weingart SN, Flug J, Brouillard D, et al. Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ 2007;334:407.
7. Wood L. A review on adherence management in patients on oral cancer therapies. Eur J Oncol Nurs 2012;16:432-8.
8. Parsad SD, Ratain MJ. Prescribing oral chemotherapy. BMJ 2007;334:376.
9. Schneider SM, Hess K, Gosselin T. Interventions to promote adherence with oral agents. Semin Oncol Nurs 2011;27:133-41.
10. Cassidy J. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol 2002;13:566-75. (Pubitemid 34461140)
11. Walko CM, Lindley C. Capecitabine: a review. Clin Ther 2005;27:23-44. (Pubitemid 40347299)
12. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: WHO, 2003.
13. Cutler DM, Everett W. Thinking outside the pillbox-medication adherence as a priority for health care reform. N Engl J Med 2010;362:1553-5.
14. Winterhalder R, Hoesli P, Delmore G, et al. Self-reported compliance with capecitabine: findings from a prospective cohort analysis. Oncology 2011;80:29-33.
15. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 2009;59:56-66.
16. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97. (Pubitemid 41127293)
17. Waterhouse DM, Calzone KA, Mele C, et al. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 1993;11:1189-97. (Pubitemid 23163362)
18. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002;288:2880-3. (Pubitemid 35425074)
19. Spoelstra SL, Given CW. Assessment and measurement of adherence to oral antineoplastic agents. Semin Oncol Nurs 2011;27:116-32.
20. Foulon V, Schöffski P, Wolter P. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clin Belg 2011;66:85-96.
21. Partridge AH, Archer L, Kornblith AB, et al. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol 2010;28:2418-22.
22. Muss HB, Berry DA, Cirrincione CT, et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 2009;360:2055-65.
23. Mayer EL, Partridge AH, Harris LN, et al. Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer. Breast Cancer Res Treat 2009;117:615-23.
24. Bhattacharya D, Easthall C, Willoughby KA, et al. Capecitabine non-adherence: exploration of magnitude, nature and contributing factors. J Oncol Pharm Pract 2012;18:333-42.
25. Simons S, Ringsdorf S, Braun M, et al. Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Support Care Cancer 2011;19:1009-18.
26. Vrijens B, Geest S De, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73:691-705.
27. Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995;49:321-7.
28. Denhaerynck K, Schäfer-Keller P, Young J, et al. Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol 2008;8:5.
29. Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs 2013;73:545-62.
30. Noens L, Van Lierde M, Bock R De, et al. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood 2009;113:5401-11.